AMINOLOGICS (074430) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, AMINOLOGICS (074430) reported revenue of 22.0 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202522.0 billion KRW3.6 billion KRW3.5 billion KRW[source]
202416.8 billion KRW-2.2 billion KRW-1.6 billion KRW[source]
202320.9 billion KRW1.5 billion KRW2.4 billion KRW[source]
202227.3 billion KRW7.0 billion KRW-7.3 billion KRW[source]
202122.8 billion KRW4.1 billion KRW5.4 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202584.2 billion KRW28.2 billion KRW56.0 billion KRW[source]
202456.8 billion KRW5.1 billion KRW51.7 billion KRW[source]
202357.7 billion KRW3.3 billion KRW54.4 billion KRW[source]
202255.6 billion KRW4.2 billion KRW51.4 billion KRW[source]
202165.2 billion KRW5.8 billion KRW59.4 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice